Publications
5674 Results
- Journal / Conference
- JCO 8(7):1155-1162
- Year
- 1990
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8410
M-BACOD treatment for intermediate and high grade malignant lymphomas: A Southwest Oncology Group phase II trial.
- Journal / Conference
- Carboplatin Current Perspectives and Future Directions (JM-8):163-164
- Year
- 1990
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8412
Improved efficacy of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: Preliminary report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV suboptimal ovarian cancer.
- Journal / Conference
- Invest New Drugs 8:93-95
- Year
- 1990
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8426
VM-26 in colorectal carcinoma: A Southwest Oncology Group study.
- Journal / Conference
- Cancer 65:866-869
- Year
- 1990
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-8465
High-dose cisplatin for metastatic soft tissue sarcoma. A Southwest Oncology Group study.
- Journal / Conference
- JCO 8(12):1951-1958
- Year
- 1990
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8503
Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: A Groupwide Southwest Oncology Group study.
- Journal / Conference
- Invest New Drugs 8:S69-S71
- Year
- 1990
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8504
Evaluation of menogaril in renal cell carcinoma. A Southwest Oncology Group phase II study.
- Journal / Conference
- IND 8:381-383
- Year
- 1990
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-8505
Phase II trial of echinomycin in advanced soft tissue sarcomas: A Southwest Oncology Group study.
- Journal / Conference
- EJC 26(7):848-849
- Year
- 1990
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8519
Methyl-glyoxal bis-guanylhydrazone (MGBG) in advanced bladder cancer.
- Journal / Conference
- Journal of Interferon Research 10:531-534
- Year
- 1990
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-8526
Phase II evaluation of recombinant beta interferon (IFN-Bser) in patients with diffuse mesothelioma: A Southwest Oncology Group study.
- Journal / Conference
- Cancer Chemo and Pharm 25:373-376
- Year
- 1990
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-8562